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infarction (STEMI).1,2 There are conflicting results 
regarding the outcomes of patients with STEMI 
undergoing off ‑hour (weekday nights, weekends, 
and holidays) pPCI.1-7 Some investigators have 
reported higher mortality rates in that popula‑
tion,1-4 while others showed no differences.5-7 
Healthcare delivery variations, the degree of cath‑
eterization laboratory loading in the scheduled 
INTRODUCTION According to existing data, it has 
been suggested that hospital admission during 
the day and at night may influence the short‑ and 
long ‑term clinical outcomes of patients with acute 
myocardial infarction (AMI) treated with prima‑
ry percutaneous coronary intervention (pPCI).1,2 
The majority of studies on this issue focus on 
patients with ST ‑segment elevation myocardial 
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INTRODUCTION It has been suggested that the time of admission during the day and night may influ‑
ence the clinical outcomes of patients with acute myocardial infarction (AMI) treated with percutaneous 
coronary intervention (PCI).
OBJECTIVES The aim of this study was to assess the impact of day‑ and night ‑time admissions on 
the clinical outcomes of patients with AMI undergoing PCI.
PATIENTS AND METHODS This retrospective cohort study was based on the data on PCIs performed in 
Poland from January 2014 to December 2017, prospectively collected in the National Registry of Invasive 
Cardiology Procedures (ORPKI). Day hours were defined as the time interval between 7:00 am and 10:59 
pm. The study endpoints included the all ‑cause in ‑hospital mortality rate and major adverse cardiovascular 
and cerebrovascular events (MACCEs) at 30 ‑day, 12 ‑month, and 36 ‑month follow ‑up.
RESULTS A total of 2919 patients were included in the study (2462 [84.3%] treated during the day hours). 
ST ‑segment elevation myocardial infarction (1993 [68.3%]) was the main indication for PCI. We demonstrated 
that the 30 ‑day mortality rate was significantly higher in patients treated during the night hours than during 
the day hours (P = 0.01). Night hours were also among the independent predictors of increased 30 ‑day 
mortality (hazard ratio, 1.54; 95% CI, 1.11–2.16; P = 0.01). No significant differences were observed in 
in ‑hospital, 12 ‑month, and 36 ‑month mortality rates between patients treated during the night and day 
hours. There were no significant differences in the MACCE rates at the follow ‑up timepoints.
CONCLUSIONS Primary PCI for AMI is associated with increased 30 ‑day mortality among patients treated 
during the night hours compared with those managed during the day hours.
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whereas night hours as the time interval between 
11:00 pm and 6:59 am.
Pain ‑to ‑balloon (PTB) time was defined as 
the time from the AMI symptom onset to the first 
inflation of a catheter balloon within the culprit 
lesion. All study patients were divided into groups 
by PTB times: patients with a PTB time shorter 
than 3 hours (group 1), patients with a PTB time 
longer than 3 hours but shorter than 12 hours 
(group 2), and patients with a PTB time longer 
than 12 hours but shorter than 24 hours (group 
3). The overall group of patients with AMI was 
also evaluated for the type of AMI: STEMI and 
non–ST ‑segment elevation myocardial infarc‑
tion (NSTEMI). First ‑medical ‑contact ‑to ‑balloon 
time was defined as the time from the first med‑
ical contact of the patient with AMI to catheter 
balloon inflation in the culprit artery.
Primary percutaneous coronary intervention proto-
col Both intervention strategy and device choice 
were at the discretion of the attending physician. 
Pharmacological treatment was administered ac‑
cording to current guidelines.10,11
Study endpoints The primary study endpoints 
included all ‑cause mortality and major ad‑
verse cardiovascular and cerebrovascular events 
(MACCEs). The latter involved coronary revascu‑
larization (repeated percutaneous coronary revas‑
cularization or coronary artery bypass grafting), 
cerebral stroke or transient ischemic attacks, myo‑
cardial infarction, and the overall mortality rate.
Statistical analysis Categorical variables were 
presented as number and percentage. Contin‑
uous variables were expressed as mean (SD) or 
median (interquartile range) where applicable. 
Normality of data distribution was assessed us‑
ing the Shapiro–Wilk test. Equality of variances 
was evaluated with the Levene test. Differenc‑
es between the 2  study groups were compared 
using the Student or Welch t test depending on 
the equality of variances for normally distribut‑
ed variables. The Mann–Whitney test was used 
for nonnormally distributed continuous vari‑
ables. Categorical variables were compared with 
the Pearson χ2 or the Fisher exact test. Multi‑
ple group comparisons were performed using 
the analysis of variance or the Kruskal–Wallis test. 
The Tukey–Kramer honest significant difference 
test or the Steel–Dwass method were used for 
post hoc comparisons. For categorical parameters 
and survival analyses, the Benjamini–Hochberg 
procedure was applied to adjust the P value. Uni‑
variable and multivariable Cox proportional haz‑
ard models were performed to identify the pre‑
dictors of MACCEs and death. Factors included 
in the adjusted model were as follows: admission 
time, type of MI, age, smoking status, hyperten‑
sion, Killip class, sex, diabetes, kidney disease, 
previous stroke, previous MI, previous PCI, car‑
diac arrest at baseline, chronic obstructive pul‑
monary disease, treatment with acetylsalicylic 
mode of the day, traffic volume during the day 
and night, fatigue, and operators’ experience are 
listed among the factors that could potentially in‑
fluence this association.8
Therefore, the aim of this study was to assess 
the impact of day‑ and night ‑time PCIs on pa‑
tients’ long ‑term clinical outcomes, considering 
the effect of the time from symptom onset to PCI 
and the type of myocardial infarction.
PATIENTS AND METHODS Study design, population, 
and eligibility criteria This retrospective cohort 
study was based on the data prospectively collect‑
ed in the National Registry of Invasive Cardiology 
Procedures (Polish, Ogólnopolski Rejestr Proce‑
dur Kardiologii Inwazyjnej [ORPKI]). The registry 
was described elsewhere.9 All consecutive patients 
admitted between January 2014 and December 
2017, diagnosed with acute myocardial infarction 
(AMI) according to the current European guide‑
lines,10,11 and treated with PCI were included in 
this study. Then, the data received from the OR‑
PKI registry were matched with the data from 
the Polish National Health Fund (Polish, Nar‑
odowy Fundusz Zdrowia [NFZ]). When merging 
the databases, the following characteristics were 
considered: age, sex, catheterization laboratory, 
and the date of the procedure. The data analyzed 
here came from the Świętokrzyskie Province and 
included procedures carried out in the above spec‑
ified period in 7 catheterization laboratories. We 
evaluated the subsequent follow ‑up timepoints 
obtained from the NFZ records after 30, 183, 365, 
and 1095 days in order to compare them with 
the results of previous studies. None of the study 
patients were lost to follow ‑up. Hospitals and 
catheterization laboratories participating in our 
study were included into the 24/7 network pro‑
viding pPCI. Since the ORPKI registry is based 
on current clinical practice data, only standard 
written informed consent for PCI and data col‑
lection was obtained from the study patients. 
The study protocol complied with the Declara‑
tion of Helsinki.
Study definitions Day hours were defined as 
the time interval between 7:00 am and 10:59 pm, 
WHAT’S NEW?
It has been suggested that admission during the day and at night may influ‑
ence the clinical outcomes of patients with acute myocardial infarction (AMI) 
treated with primary percutaneous coronary intervention. In this retrospective 
cohort study, we aimed to investigate that association based on data from 
the National Registry of Invasive Cardiology Procedures (Polish, Ogólnopol‑
ski Rejestr Procedur Kardiologii Inwazyjnej [ORPKI]). We demonstrated that 
the 30 ‑day mortality rate was significantly higher in patients treated during 
the night hours than during the day hours. The night hours were also among 
the independent predictors of increased 30 ‑day mortality. The in ‑hospital, 
12 ‑month, and 36 ‑month all ‑cause mortality were nonsignificantly higher in 
patients treated during the night hours compared with the day hours.
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with STEMI (P <0.001). Other procedural char‑
acteristics are shown in TABLE 2.
Clinical endpoints The in ‑hospital mortality rate 
was almost 2 ‑fold higher in the STEMI group com‑
pared with the NSTEMI group (P <0.001) and it re‑
mained higher at 30 days (P = 0.009) (TABLE 3). This 
difference was not observed at the subsequent 
timepoints. The 30 ‑day mortality rate was higher 
in patients treated during the night hours com‑
pared with the day hours (P = 0.009) and this dif‑
ference disappeared at the subsequent timepoints 
(FIGURE 1A and 1B, TABLE 3). The combined character‑
istics of patients also demonstrated that the low‑
est survival rate at 30 days was seen in those 
treated during the night hours and with the lon‑
gest PTB time (P = 0.016), which was nonsignifi‑
cant at 36 months (P = 0.17) (FIGURE 2A and 2B). In 
terms of PTB times and mortality at 36 months, 
patients with the longest waiting time for PCI 
(longer than 12 hours but shorter than 24 hours) 
were characterized by the highest mortality rate 
compared with those from other groups in which 
the delay was shorter than 12 hours (P = 0.01) 
(FIGURE 3).
Predictors of death at selected timepoints  Multi‑
variable Cox regression analysis at 30 days dem‑
onstrated that the following were among the sig‑
nificant predictors of all ‑cause mortality: admis‑
sion during night hours (hazard ratio [HR], 1.54; 
95% CI, 1.11–2.16), STEMI (HR, 1.53; 95% CI, 
1.10–2.12), diabetes (HR, 1.78; 95% CI, 1.31–2.43), 
kidney disease (HR, 2.79; 95% CI, 1.62–4.81), car‑
diac arrest at baseline (HR, 7.49; 95% CI, 4.89–
11.48), age (HR, 1.08; 95% CI, 1.06–1.09), a high‑
er Killip class (HR, 2.19; 95% CI, 1.85–2.55), pa‑
tency of the culprit coronary artery before (HR, 
0.67; 95% CI, 0.55–0.81) and after PCI (HR, 
0.52; 95% CI, 0.45–0.63), smoking status (HR, 
0.54; 95% CI, 0.37–0.79), and male sex (HR, 0.5; 
95% CI, 0.38–0.66) (FIGURE 4A).
At 12 months, the significant mortality pre‑
dictors included: diabetes (HR, 1.74; 95% CI, 
1.36–2.22), kidney disease (HR, 2.7; 95% CI, 
1.74–4.21), previous cerebral stroke (HR, 2.7; 
95% CI, 1.8–4.07), cardiac arrest at baseline (HR, 
5.4; 95% CI, 3.64–8.02), age (HR, 1.07; 95% CI, 
1.06–1.09), a higher Killip class on admission 
(HR, 1.95; 95% CI, 1.68–2.24), patency of the cul‑
prit coronary artery before (HR, 0.83; 95% CI, 
0.72–0.94) and after PCI (HR, 0.61; 95% CI, 
0.53–0.73), smoking status (HR, 0.52; 95% 
CI, 0.38–0.7), and male sex (HR, 0.53; 95% CI, 
0.42–0.66) (FIGURE 4B).
The significant predictors of mortality at the 
36 ‑month follow ‑up included: diabetes (HR, 1.69; 
95% CI, 1.37–2.09), kidney disease (HR, 2.78; 95% 
CI, 1.89–4.07), previous cerebral stroke (HR, 2.77; 
95% CI, 1.96–3.91), previous MI (HR, 1.45; 95% 
CI, 1.13–1.87), cardiac arrest at baseline (HR, 4.77; 
95% CI, 3.31–6.87), age (HR, 1.08; 95% CI, 1.07–
1.09), a higher Killip class on admission (HR, 1.78; 
95% CI, 1.55–2.03), smoking status (HR, 0.54; 
acid at baseline, and Thrombolysis in Myocardi‑
al Infarction (TIMI) flow grade before and after 
PCI. All statistical analyses were performed with 
the JMP software, version 14.2.0 (SAS Institute, 
Inc., Cary, North Carolina, United States), and 
statistical tests were 2 ‑sided (a P value less than 
0.05 was considered significant).
RESULTS General characteristics The total num‑
ber of patients included in the study was 2919. 
Among them, there were 2462 patients treated 
during the day hours (84.3%) and 457 patients 
treated during the night hours (15.7%). The main 
indication for PCI was STEMI, which was reported 
in 1993 patients (68.3%), whereas NSTEMI was 
noted in 926 patients (31.7%). The PTB time of 
up to 3 hours (group 1) was recorded in 1000 pa‑
tients (34.3%), longer than 3 hours but not ex‑
ceeding 12 hours (group 2) in 1452 (49.7%), and 
longer than 12 hours but shorter than 24 hours 
(group 3) in 467 (16%).
Pain -to -balloon time Patients treated for AMI, 
when assessed by the PTB time, were older in 
group 3 compared with groups 1 and 2 (P <0.001). 
The greatest percentage of patients treated during 
the day hours was seen in group 3 compared with 
groups 1 and 2 (P <0.001). Pharmacological treat‑
ment received by the study patients is present‑
ed in TABLE 1. Patients from groups 2 and 3 were 
more often treated via radial access (P <0.001). 
These and other procedural characteristics are 
summarized in TABLE 2.
Time of percutaneous coronary intervention (day ver-
sus night hours) Patients treated for AMI dur‑
ing the day hours were older compared with 
those treated during the night hours (P = 0.02). 
In the overall group of patients treated for AMI, 
there were more individuals from groups 2 and 
3 undergoing PCI during the day hours in com‑
parison to those managed during the night hours 
(P <0.001). When assessed separately, in both 
STEMI and NSTEMI patients, there were more 
individuals from groups 2 and 3 treated dur‑
ing the day hours than during the night hours, 
but a significant difference was found only for 
NSTEMI (P <0.001). Also, first ‑medical ‑contact‑
‑to ‑balloon times were longer during the day 
hours compared with the night hours (P <0.001) 
and, again, this difference was significant only in 
the NSTEMI group (P <0.001). Additionally, more 
patients presented with less severe general con‑
dition according to the Killip class (grade 1) dur‑
ing the day hours compared with the night hours 
(P = 0.04) (TABLES 1 and 2).
Type of myocardial infarction: ST -segment eleva-
tion myocardial infarction versus non–ST -segment 
elevation myocardial infarction Patients treated 
for NSTEMI were older than those with STEMI 
(P <0.001). The burden of concomitant diseases 
was greater in patients with NSTEMI. The femo‑
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TABLE 1 Baseline clinical characteristics of the study patients by time from pain onset to balloon inflation, day and night admission hours, and type of myocardial infarction
Selected indices PTB time P value Time of PCI P value Type of MI P value
0–3 hours (n [%], 
1000 [34.2])
3–12 hours (n [%], 
1452 [49.7])
12–24 hours (n [%], 
467 [16])
Day (n [%], 
2462 [84.3])
Night (n [%], 
457 [15.7])
NSTEMI (n [%], 
926 [31.7])
STEMI (n [%], 
1993 [68.3])
Age, y, mean (SD) 64.6 (11.9) 66.7 (12.1) 67.8 (12.6) <0.001a,b 66.4 (12.2) 64.9 (12.1) 0.02 67.7 (12.2) 65.3 (12.1) <0.001
Male sex, n 714 (71.4) 932 (64.2) 303 (64.9) <0.001a,b 1643 (66.7) 306 (66.9) 0.92 597 (64.5) 1352 (67.8) 0.07
Day hours, n 798 (79.8) 1242 (85.5) 422 (90.3) <0.001a,b,c – – – 840 (90.7) 1622 (84) <0.001
PTB, min, 
median (IQR)
Overall – – – – 270 (163–565) 205 (137–401) <0.001 550 (300–870) 200 (137–335) <0.001
STEMI – – – – 205 (140–335) 188 (131–348) 0.56 – –
NSTEMI – – – – 577 (330–900) 346 (180–666) <0.001 – –
FMCTB, min, 
median (IQR)
Overall – – – – 103 (60–218) 80 (55–130) <0.001 236 (105–495) 80 (52–120) <0.001
STEMI – – – – 80 (50–120) 75 (54–120) 0.7 – –
NSTEMI – – – – 240 (115–531) 120 (60–272) <0.001 – –
Diabetes 161 (16.1) 262 (18) 96 (20.5) 0.1 451 (18.3) 68 (14.9) 0.07 170 (18.3) 349 (17.5) 0.57
Smoking status 277 (27.7) 346 (23.8) 124 (26.5) 0.08 625 (25.4) 122 (26.7) 0.55 242 (26.1) 505 (25.3) 0.64
Arterial hypertension 613 (61.3) 928 (63.9) 312 (66.8) 0.1 1590 (64.6) 263 (57.5) 0.004 627 (67.7) 1226 (61.5) 0.001
Kidney failure 20 (2) 38 (2.6) 22 (4.7) 0.01b,c 72 (2.9) 8 (1.7) 0.15 37 (4) 43 (2.1) 0.004
Previous stroke 30 (3) 39 (2.7) 22 (4.7) 0.08 82 (3.3) 9 (2) 0.12 30 (3.2) 61 (3.1) 0.79
Previous MI 100 (10) 165 (11.4) 91 (14.5) <0.001b,c 308 (12.5) 48 (10.5) 0.22 150 (16.2) 206 (10.3) <0.001
Previous PCI 89 (8.9) 135 (9.3) 60 (12.8) 0.04b,c 252 (10.2) 32 (7) 0.03 108 (11.7) 176 (8.8) 0.01
COPD 6 (0.8) 13 (1.4) 4 (1.35) 0.5 17 (0.7) 6 (1.3) 0.16 10 (1.6) 13 (0.95) 0.2
Killip class I / II 605 (95.6) 821 (95.3) 273 (96.8) 0.79 1429 (96.1) 270 (93.4) 0.11 568 (96.3) 1131 (95.4) 0.055
III 12 (1.9) 22 (2.6) 6 (2.1) 30 (2) 10 (3.4) 8 (1.4) 32 (2.7)
IV 16 (2.5) 18 (2.1) 3 (1.1) 28 (1.9) 9 (3.1) 14 (2.4) 23 (1.9)
Type of MI NSTEMI 100 (10) 502 (34.6) 321 (68.7) <0.001a,b,c 837 (34) 86 (18.8) <0.001 – – –
STEMI 900 (90) 949 (65.3) 145 (31) 1623 (65.9) 371 (81.2) – – –
Cardiac arrest 38 (3.8) 22 (1.5) 2 (0.4) <0.001a,b 47 (1.9) 15 (3.3) 0.06 10 (1.1) 52 (2.6) 0.008
ASA 558 (55.8) 851 (58.6) 266 (56.9) 0.37 1418 (57.6) 257 (56.2) 0.58 525  (56.7) 1150 (57.7) 0.6
P2Y12 inhibitor 459 (45.9) 647 (44.5) 174 (37.2) <0.001b,c 1094 (44.4) 186(40.7) 0.13 333 (35.9) 947 (47.5) 0.047
Clopidogrel 432 (43.2) 612 (42.1) 165 (35.3) 0.01b,c 1031 (41.9) 178 (38.9) 0.24 327 (35.3) 882 (44.2) 0.003
Ticagrelor 20 (0.2) 15 (1.4) 6 (1.3) 0.13 38 (1.5) 3 (0.6) 0.13 3 (0.3) 38 (1.9) 0.01
Prasugrel 7 (0.07) 20 (1) 3 (0.6) 0.2 25 (1) 5 (1.1) 0.87 3 (0.3) 27 (1.3) 0.07
Data are presented as number (percentage) of patients unless otherwise indicated.
a Post hoc analysis for the PTB time comparisons: P <0.05 for PTB <3 hours vs 3 <PTB <12 hours
b Post hoc analysis for the PTB time comparisons: P <0.05 for PTB <3 hours vs 12 <PTB <24 hours
c Post hoc analysis for the PTB time comparisons: P <0.05 for 3 <PTB <12 hours vs 12<PTB<24 hours
Abbreviations: ASA, acetylsalicylic acid; COPD, chronic obstructive pulmonary disease; FMCTB, first ‑medical‑contact ‑to ‑balloon; MI, myocardial infarction; NSTEMI, non–ST ‑segment elevation myocardial infarction; PCI, percutaneous 
coronary intervention; PTB, pain ‑to ‑balloon; STEMI, ST ‑segment elevation myocardial infarction
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a meta ‑analysis, it was demonstrated that the off‑
‑hour patients tended to have a more serious con‑
dition, considering the incidence of cardiogenic 
shock or the Killip class.1,4 However, other authors 
did not suggest such differences.5,12-16 Clinical dif‑
ferentiation indicated by the Killip class in our 
study was considered similar to that presented 
in other reports: the percentage of patients dem‑
onstrating a higher Killip class was greater dur‑
ing the night hours. In a study by Casella et al,17 
it was shown that when pPCIs were performed 
in a highly specialized STEMI network, the clini‑
cal efficacy of off ‑hour and regular ‑hour pPCI was 
similar, regardless of the region. The baseline clin‑
ical and angiographic characteristics did not dif‑
fer between patients treated during office‑ and 
off ‑hours.17 In contrast, we noted various signif‑
icant differences related to these characteristics, 
including concomitant diseases, clinical status 
on hospital admission, and AMI type. In anoth‑
er study,4 the number of patients receiving treat‑
ment during off hours was smaller; however, these 
patients were more seriously ill. It has been not‑
ed that less frequent performance of pPCIs dur‑
ing weekends is related to poorer outcomes. This 
association was observed at 3 follow ‑up periods, 
depending on the study:1,3 during hospitalization, 
at 30 days, and at up to 12 months. Comparing 
day‑ and night ‑hours, our study indicated that 
the PTB times were longer in patients with STEMI 
and those with NSTEMI during the night hours. 
Nonetheless, differences were significant only 
with regard to patients with NSTEMI. Prolonged 
PTB times were reflected in significantly higher 
all ‑cause mortality at 30 days. There were differ‑
ences between the data provided by Casella et al17 
and Rathore et al.12 The latter analyzed 43 801 
patients with STEMI treated with pPCI and ob‑
served that any kind of delay after the patient’s 
arrival to the hospital was associated with a great‑
er mortality risk.12 Yet, in another large registry, 
it was shown that a substantial number of pa‑
tients who were treated during off hours were 
subjected to a door ‑to ‑balloon (DTB) time longer 
than 120 minutes (41.5% during the off hours vs 
27.7% during the regular hours; P <0.001).1 Gla‑
ser et al4 obtained similar results. After exclud‑
ing patients presenting with cardiogenic shock, 
the prolonged DTB time remained to be associ‑
ated with a higher mortality rate. The detrimen‑
tal influence of a longer DTB time may be con‑
sidered substantial in very high ‑risk patients.18
In a meta ‑analysis, Sorita et al19 investigated 
46 studies including 1 869 859 participants and 
indicated that patients with AMI treated during 
off hours show a higher mortality rate, whereas 
patients with STEMI are characterized by a lon‑
ger DTB time. A higher mortality rate during off 
hours was noted both with regard to death rates 
during in ‑hospital monitoring and at the 30 ‑day 
follow ‑up.19 In our study, we found no confirma‑
tion for the association between the PTB time 
and outcomes of night‑ versus daytime treat‑
ment. Nevertheless, previous studies suggested 
95% CI, 0.42–0.69), patency of the culprit artery 
before (HR, 0.88; 95% CI, 0.78–0.97) and after 
PCI (HR, 0.64; 95% CI, 0.56–0.74), and male sex 
(HR, 0.56; 95% CI, 0.47–0.68). (FIGURE 4C).
Effect of type of myocardial infarction, time of percuta-
neous coronary intervention, and pain -to -balloon time 
on all -cause mortality at follow -up The association 
between the 30 ‑day mortality of patients and 
the type of MI, time of PCI, and PTB time as pre‑
dictors of death was investigated using the mul‑
tivariable Cox model. The risk of death, adjusted 
for the type of MI and PTB time, was 1.48 ‑fold 
(95% CI, 1.05–2.07) higher among patients un‑
dergoing PCI at night compared with those treat‑
ed during the day hours (P = 0.02). Also, the risk 
of death was 1.59 ‑fold (95% CI, 1.11–2.28) high‑
er in patients treated for STEMI compared with 
those treated for NSTEMI (P = 0.01). Regarding 
the 12 ‑month mortality rate, patients treated for 
AMI with the PTB time between 12 and 24 hours 
were at a 1.49 ‑fold (95% CI, 1.04–2.13) higher risk 
of death in comparison to those with the PTB time 
of up to 3 hours (P = 0.02). In terms of mortal‑
ity at 36 months, patients treated with PCI for 
AMI with the PTB time between 12 and 24 hours 
were at a 1.5 ‑fold (95% CI, 1.11–2.05) higher risk 
of death compared with those with the PTB time 
of up to 3 hours (P = 0.008). Furthermore, pa‑
tients with the PTB time between 3 and 12 hours 
were at 1.34 ‑fold (95% CI, 1.07–1.67) higher risk 
of death compared with patients with the PTB 
time of up 3 hours (P = 0.009).
DISCUSSION In this study, the mortality rate 
at 30 days turned out to be significantly higher in 
patients treated for AMI during the night hours 
compared with those treated during the day. At 36 
months, the all ‑cause mortality rate was higher in 
patients with a longer PTB time (12 to 24 hours). 
Comparing patients with NSTEMI and STEMI, 
the all ‑cause mortality at 30 days was higher in 
those with STEMI. The AMI type (STEMI) and 
the PCI time (during the night hours) were found 
to be the significant predictors of higher all ‑cause 
mortality during the 30 ‑day follow ‑up.
In our study, as compared with other reports, 
the time interval for night hours was limited to 
a very narrow range. It resulted from the authors’ 
experience with night shifts and showed the asso‑
ciation between true night hours and treatment 
results, providing a new perspective on the an‑
alyzed issue. As a consequence, in this section, 
we referred to studies using other time inter‑
vals, which was due to lack of available reports 
adopting the same time intervals as in the pres‑
ent study.
One of the main factors influencing the results 
of treatment depending on the time of admis‑
sion to the hospital in patients with AMI treat‑
ed with pPCI is the patient’s initial risk, which is 
determined based on, among others, their clin‑
ical status on admission and burden of concom‑
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TABLE 2 Baseline procedural characteristics of the study patients by time from pain onset to balloon inflation, day and night admission hours, and type of myocardial infarction
Selected indices PTB time P value Time of PCI P value Type of MI P value
0–3 hours (n [%], 
1000 [34.2])
3–12 hours (n [%], 
1452 [49.7])
12–24 hours 
(n [%], 467 [16])
Day (n [%], 2462 
[84.3])
Night (n [%], 457 
[15.7])
NSTEMI (n [%], 
926 [31.7])
STEMI (n [%], 
1993 [68.3])
Vascular access Femoral 543 (54.3) 712 (49.2) 167 (35.8) <0.001a,b,c 1165 (47.4) 257 (56.3) 0.01 286 (39.4) 1060 (54) <0.001
Radial 456 (45.6) 733 (50.7) 299 (64.2) 1289 (52.5) 199 (43.6) 438 (60.3) 881 (45.3)
Other 1 (0.1) 2 (0.1) 0 3 (0.1) 0 2 (0.28) 3 (0.15)
Angiography findings SVD 601 (60.1) 704 (48.6) 181 (38.9) <0.001a,b,c 1224 (49.8) 262 (57.3) 0.08 374 (40.4) 1112 (56) <0.001
MVD 301 (30.1) 570 (39.3) 206 (44.3) 933 (37.9) 144 (31.5) 358 (38.7) 719 (36.1)
MVD + LMCA 62 (6.2) 106 (7.3) 37 (8) 177 (7.2) 28 (6.1) 84 (9.1) 121 (6.1)
Separate LMCA 7 (0.7) 7 (0.5) 0 11 (0.4) 3 (0.6) 4 (0.4) 10 (0.5)
Other 29 (2.9) 63 (4.3) 41 (8.8) 113 (4.6) 20 (4.4) 105 (11.3) 28 (1.4)
Imaging (FFR, IVUS, OCT) 1 (0.1) 6 (0.41) 4 (0.85) 0.07 10 (0.4) 1 (0.2) 1 4 (0.4) 7 (0.3) 0.75
Bridge 2 (0.36) 2 (0.3) 0 0.69 4 (0.3) 0 1 0 4 (0.4) 0.32
Fistula 0 1 (0.15) 1 (0.5) 0.27 2 (0.2) 0 1 2 (0.47) 0 0.09
Dissection 1 (0.1) 0 0 0.51 1 (0.04) 0 1 0 1 (0.05) 1
TIMI before PCI 0 564 (59.7) 643 (49.3) 143 (37) <0.001a,b,c 1095 (49.5) 255 (60.4) <0.001 180 (25.1) 1170 (61) <0.001
1 242 (25.6) 333 (25.5) 91 (23.6) 572 (25.8) 94 (22.3) 227 (31.6) 439 (22.9)
2 100 (10.6) 203 (15.6) 85 (22) 337 (15.2) 51 (12.1) 164 (22.8) 224 (11.7)
3 39 (4.1) 125 (9.6) 67 (17.3) 209 (9.4) 22 (5.2) 147 (20.5) 84 (4.4)
TIMI after PCI 0 7 (0.7) 24 (1.8) 11 (2.8) 0.02a,b 32 (1.4) 10 (2.4) 0.41 12 (1.7) 30 (1.6) 0.98
1 6 (0.6) 16 (1.2) 6 (1.5) 22 (1) 6 (1.4) 11 (1.5) 17 (0.9)
2 30 (3.2) 58 (4.5) 16 (4.1) 93 (4.2) 11 (2.6) 20 (2.8) 84 (4.4)
3 902 (95.4) 1201 (92) 353 (91.4) 2061 (93.3) 395 (93.6) 672 (94) 1784 (93)
Data are presented as number (percentage) of patients unless otherwise indicated.
a Post hoc analysis for the PTB time comparisons: P <0.05 for PTB <3 hours vs >3 <PTB <12 hours
b Post hoc analysis for the PTB time comparisons: P <0.05 for PTB <3 hours vs 12 <PTB <24 hours
c Post hoc analysis for the PTB time comparisons: P <0.05 for 3 <PTB <12 hours vs 12 <PTB <24 hours
Abbreviations: FFR, fractional flow reserve; IVUS, intravascular ultrasound; LMCA, left main coronary artery; MVD, multivessel disease; OCT, optical coherence tomography; SVD, single ‑vessel disease; TIMI, Thrombolysis in 
Myocardial Infarction; others, see TABLE 1
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also yielded inconsistent results.6,12,13,22 At the 
time when we performed our analysis, the num‑
ber of high ‑risk and STEMI patients was high‑
er during the night hours. For that reason, in‑
‑hospital and 30 ‑day mortality rates were higher 
at night than during the day. This outcome was 
not considered significant at 12 and 36 months. 
It can be explained by the fact that until those 
timepoints, high ‑risk patients did not survive or 
survived only in a minority of cases. The avail‑
ability of the experienced staff, diagnostic tests, 
the number of physicians or nursing staff at the 
cardiac care unit, and human factors including 
sleep deprivation and fatigue have been consid‑
ered risk factors predisposing a patient to an in‑
creased risk of death during off hours.23 In an‑
other study, it was demonstrated that the 30 ‑day 
mortality rate was higher in patients with AMI 
treated in regions where a small number of car‑
diologists is available compared with those treat‑
ed in high‑density regions. Therefore, it can be 
suggested that the outcomes of patients with 
AMI may be affected by cardiologist availabili‑
ty in a regional healthcare system.24
In studies investigating the time from symp‑
tom onset to hospital admission, the prehospital 
delay for off hours was either shorter,25 longer,21 
or no difference was indicated2,4 -6,17,26,27 com‑
pared with office ‑hour admission. Ting et al28 not‑
ed that the prehospital delay was shorter during 
off hours both in patients with STEMI and those 
with NSTEMI. In our study, similar conclusions 
were reached. Apart from the fact that patients 
that patients with AMI admitted to the hospital 
during off hours are at greater risk of death.1,3,20,21 
According to some authors, the higher mortali‑
ty rate observed during off hours may be caused 
by the lower probability of obtaining evidence‑
‑based treatment or appropriate reperfusion ther‑
apies.1 We reject this explanation, because such 
associations have not been noted. What is more, 
a trend indicating an inverse association was ob‑
served. Instead, it seems to be of importance that, 
as a rule, pPCIs are performed during the night 
hours only in patients in whom urgent pPCI is 
absolutely necessary and who cannot wait for 
this procedure to be performed during the day 
hours. These patients are among the vast major‑
ity of high ‑risk individuals. Another issue cov‑
ered in previous reports is the quality of care pro‑
vided during off hours. It may be lower because 
of deficits in the hospital staff and expertise.3 
The abovementioned association does not ap‑
pear to be present in the database analyzed by 
our team. Nonetheless, it may be seen for PCIs 
performed on night duty and by operators at ter‑
tiary centers having less experience.
Magid et al1 also indicated that patients with 
STEMI admitted during off hours demonstrat‑
ed higher in ‑hospital mortality rates and longer 
DTB times.1 On the other hand, Jneid et al8 did 
not report any significant differences regard‑
ing mortality rates among patients with AMI 
during off and regular hours, despite the fact 
that the DTB times were longer during the off 
hours in patients with STEMI. Other studies 
TABLE 3 Follow ‑up of clinical outcomes at selected timepoints by time from pain onset to balloon inflation, day and night admission hours, and type 
of myocardial infarction
Outcome PTB time P value Time of PCI P value Type of MI P value
0–3 hours 
(n [%], 1000 
[34.2])
3–2 hours 
(n [%], 1452 
[49.7])
12–24 hours 
(n [%], 467 
[16])
















67 (6.7) 81 (5.57) 24 (5.41) 0.38 137 (5.6) 35 (7.7) 0.08 33 (3.6) 139 (7) <0.001
30 ‑day 
mortality
68 (6.8) 101 (6.96) 31 (6.64) 0.96 156 (6.3) 44 (9.6) 0.01 47 (5.1) 153 (7.7) 0.009
12 ‑month 
mortality
98 (9.8) 170 (11.7) 58 (12.4) 0.21 268 (10.9) 58 (12.7) 0.26 94 (10.1) 232 (11.6) 0.23
36 ‑month 
mortality
127 (12.7) 239 (16.5) 81 (17.34) 0.01a,b 375 (15.2) 72 (15.7) 0.77 139 (15) 308 (15.4) 0.75
30 ‑day 
MACCEs
233 (23.3) 310 (21.3) 110 (23.5) 0.42 554 (22.5) 99 (21.7) 0.69 199 (21.5) 454 (22.8) 0.43
12 ‑month 
MACCEs
442 (44.2) 666 (45.9) 218 (46.7) 0.6 1003 (40.7) 175 (38.3) 0.32 351 (37.9) 827 (41.5) 0.06
36 ‑month 
MACCEs
442 (44.2) 666 (45.9) 218 (46.7) 0.6 1131 (46) 195 (42.7) 0.19 404 (43.6) 922 (46.2) 0.18
Data are presented as number (percentage) of patients unless otherwise indicated.
a Post hoc analysis for the PTB time comparisons: P <0.05 for PTB <3 hours vs 3 <PTB <12 hours
b Post hoc analysis for the PTB time comparisons: P <0.05 for PTB <3 hours vs 12 <PTB <24 hours
c Post hoc analysis for the PTB time comparisons: P <0.05 for 3 <PTB <12 hours vs 12 <PTB <24 hours
Abbreviations: MACCEs, major adverse cardiovascular and cerebrovascular events; others, see TABLE 1
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needs to be completed before starting PCI in an‑
other patient with AMI. Furthermore, this dif‑
ference may also be influenced by the larger per‑
centage of patients with NSTEMI undergoing day‑
‑time treatment, reflecting various attitudes to‑
wards invasive treatment in this patient group.10,11
Study limitations In contrast to the majority 
of studies assessing the relation between clini‑
cal outcomes in patients with AMI treated with 
admitted during the night hours were more se‑
riously ill compared with those admitted during 
the day, undoubtedly, other factors could substan‑
tially influence our findings. Among them, great‑
er ambulance accessibility, reduced traffic volume, 
and a lower burden of catheterization laborato‑
ries with elective procedures can be listed. The oc‑
currence of these factors may delay the transpor‑
tation of AMI patients with, eg, life ‑threatening 
complications of elective PCI, as one procedure 
FIGURE 1 Survival 
curves for grouping 
variables, day versus 
night hours: cumulative 
hazard at 30 days (A) and 
1095 days (B)
Number at risk 
Number at risk 
  
Night 457 420 413 408 403 402 401
Day 2462 2339 2286 2263 2244 2230 2217
Day (7 AM to 10:59 PM) Night (11 PM to 6:59 AM)






































Night  457 348 298 207 137 71 31 
Day 2462 1896 1595 1197 810 443 245 
0 365 730 1095 
A
B
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of analysis and is difficult to compare with oth‑
er studies. Moreover, patients with AMI treat‑
ed with pPCI in such a narrow night‑time inter‑
val are, in advance, at a higher risk of deteriora‑
tion, require immediate treatment, and cannot 
wait until the morning.
Conclusions A greater short ‑term all ‑cause mor‑
tality was observed in patients treated with pPCI 
for AMI during the night hours compared with 
those treated during the day hours. Patients with 
pPCI and the time of hospital admission, we 
included patients with STEMI and those with 
NSTEMI, which complicated the interpretation 
of the results. Additionally, in other studies, off 
hours were most frequently defined as weekends 
and weekdays during night shifts usually after 
5:00 pm or, in some reports, night hours inde‑
pendently of the day of the week. We extracted 
a very narrow group of patients treated very late 
(after 11:00 pm) and early in the morning (be‑
fore 7:00 am), which is not common for this type 
FIGURE 2 Survival 
curves for grouping 
variables, pain ‑to ‑balloon 
time and day versus night 
hours: cumulative hazard 
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FIGURE 3 Survival 
curves for grouping 
variables, pain ‑to ‑balloon 
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3–12 hrs 1452 1119 949 695 480 263 151 
12–24 hrs 467 364 296 228 149 78 44 
P = 0.0402
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FIGURE 4 Multivariable 
Cox regression analysis of 
mortality predictors 
at selected follow ‑up 
timepoints: cumulative 
survival at 30 days (A), 
12 months (B). Data are 
shown as hazard ratio and 
95% CI (upper and lower 
limits)—see the Results 
section; all 3 values are 
marked as black dots. 
Abbreviations: see 
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STEMI had poorer prognosis in terms of hospital 
and 30 ‑day all ‑cause mortality than those with 
NSTEMI. Among patients with AMI, pPCI during 
the night hours was associated with shorter PTB 
times in patients with NSTEMI and those with 
STEMI compared with procedures performed dur‑
ing the day hours.
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